{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/epistaxis-nosebleeds/management/acute-epistaxis/","result":{"pageContext":{"chapter":{"id":"e0220daa-0b07-5f92-af4d-9530f90352ea","slug":"acute-epistaxis","fullItemName":"Scenario: Acute epistaxis","depth":2,"htmlHeader":"<!-- begin field fa3f3247-024d-41ad-82af-5eaed62665fc --><h2>Scenario: Acute epistaxis</h2><!-- end field fa3f3247-024d-41ad-82af-5eaed62665fc -->","summary":"Covers the management of people with acute epistaxis.","htmlStringContent":"<!-- begin item 0f37ae77-2574-490f-8d59-b4170a1a55b6 --><!-- begin field ef94cf13-d84d-4f84-a7a7-acbc0158701d --><p>From age 1 month onwards.</p><!-- end field ef94cf13-d84d-4f84-a7a7-acbc0158701d --><!-- end item 0f37ae77-2574-490f-8d59-b4170a1a55b6 -->","topic":{"id":"41f6c6fa-463d-5a28-9ffa-15f68320f0ad","topicId":"4e494407-5d2a-47b0-8980-124980c278b3","topicName":"Epistaxis (nosebleeds)","slug":"epistaxis-nosebleeds","lastRevised":"Last revised in August 2020","chapters":[{"id":"8924b1cb-1830-5e93-a601-5a515e1ef05c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7267ef2e-a210-5137-a813-dac8e91b1831","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b0e06988-22ae-5f73-bb20-2033460ee20a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fb00e926-a8d3-5ae8-8f15-5dca94fff64d","slug":"changes","fullItemName":"Changes"},{"id":"a4dfa534-2e88-5962-97a7-50f5bc6903c5","slug":"update","fullItemName":"Update"}]},{"id":"182f787a-708c-5014-9591-48eddb54268d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bcaf0313-1bdc-548f-971f-dc9159fb2738","slug":"goals","fullItemName":"Goals"},{"id":"1820dda9-b7b1-5247-ad00-826f0b3f4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6508b703-ccd2-56fe-b323-3dfd267f6057","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"27ddc66a-0532-592f-be80-40b6581b9e9c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d6beda29-ddc7-569c-8f25-2395cd0b3213","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b9f6fbd-0722-5dcc-afac-e879fdfc6832","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1c7c7c7b-4f02-5cb0-af91-12ff20526fa7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6a3ef102-679b-5a9e-9d3d-73b58b70d2ef","slug":"definition","fullItemName":"Definition"},{"id":"05e8d25d-b629-5896-847e-76ab44c33576","slug":"causes","fullItemName":"Causes"},{"id":"7e0e17b8-b890-541e-92b5-0790ae3d08b5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2624ce06-f85b-541e-a7bb-589ee1197b08","slug":"prognosis","fullItemName":"Prognosis"},{"id":"7f96f0b5-4a51-5413-b0b1-73ea61f581ac","slug":"complications","fullItemName":"Complications"}]},{"id":"eee7ea0d-538e-53b8-bf4c-3333153a7978","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4ac070a5-a9e9-58a1-a125-c8a457f1833a","slug":"assessment","fullItemName":"Assessment"}]},{"id":"662dfd0d-d907-52ea-8d8b-97a3cf464cc7","fullItemName":"Management","slug":"management","subChapters":[{"id":"e0220daa-0b07-5f92-af4d-9530f90352ea","slug":"acute-epistaxis","fullItemName":"Scenario: Acute epistaxis"},{"id":"49c8979b-9af3-5eab-a574-05004fda4a4a","slug":"recurrent-epistaxis","fullItemName":"Scenario: Recurrent epistaxis"}]},{"id":"91147d78-80c8-5364-b3e1-7995b6718b2a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c7a65cbb-e7c2-50f8-b6a2-68a41e1db4cb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bb7e51c5-d888-5640-8c0b-07c8a505bf48","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3c48404f-ce42-5815-8d02-6dd6ef1ae5f3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b82f78a8-0e22-5156-bc34-baaa9c78ee15","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6093800a-eb2a-53e5-918a-e8f0be8c4ae0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6ce6588e-beaa-5a3b-a424-cfad9a225022","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1343761f-c431-50df-9bd2-a9b600c5e067","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"662dfd0d-d907-52ea-8d8b-97a3cf464cc7","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1136e498-f793-5e73-bccb-91383ada77b5","slug":"management-of-acute-epistaxis","fullItemName":"Management of acute epistaxis","depth":3,"htmlHeader":"<!-- begin field 04d46a18-ff63-41c9-8df0-80be4ee21d83 --><h3>How should I manage a person with acute epistaxis?</h3><!-- end field 04d46a18-ff63-41c9-8df0-80be4ee21d83 -->","summary":null,"htmlStringContent":"<!-- begin item 159eb36c-7ca8-454b-a5b3-b716663a3fee --><!-- begin field 88b5dffb-725a-40b8-908f-025a9c8ba427 --><ul><li><strong>If the person is <a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/diagnosis/assessment/\">assessed</a> to be haemodynamically compromised, </strong>arrange immediate transfer to Accident and Emergency.</li><li><strong>Use first aid measures to control the bleeding</strong> while awaiting hospital transfer. Ask the person to:<ul><li>Sit with their upper body tilted forward and their mouth open. They should avoid lying down, unless they are feeling faint.<ul><li>Leaning forward decreases blood flow through the nasopharynx, allows spitting out of blood, and minimizes swallowing blood that drains into the pharynx.</li></ul></li><li>Pinch the cartilaginous (soft) part of the nose firmly and hold it for 10–15 minutes without releasing the pressure, whilst breathing through their mouth.<ul><li>A common misconception is that compression of the nasal bones will help stop bleeding.</li></ul></li></ul></li><li><strong>If the person is <a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/diagnosis/assessment/\">assessed</a> to be haemodynamically stable, </strong>use first aid measures (as above) to control the bleeding.</li><li><strong>If bleeding from the posterior area of the nose is suspected (bleeding is profuse, from both nostrils, and the bleeding site cannot be identified on speculum examination), </strong>admit the person to hospital.</li><li><strong>If bleeding stops with first aid measures:</strong><ul><li>Consider applying a topical antiseptic preparation to reduce crusting and vestibulitis: prescribe Naseptin<sup>® </sup>(chlorhexidine and neomycin) cream to be applied to the nostrils four times daily for 10 days. If compliance is a problem, advise that it can be used twice daily for up to 2 weeks.</li><li>If the person is allergic to neomycin, peanut, or soya, do not prescribe Naseptin<sup>® </sup>cream. Instead, consider prescribing mupirocin nasal ointment to be applied to the nostrils two to three times a day for 5–7 days.</li><li>Consider whether admission or referral to <a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/acute-epistaxis/#secondary-care-treatments\">secondary care</a> is necessary, for example in children younger than 2 years of age (as an underlying cause is likely in this age group), if there is a likely <a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/background-information/causes/\">underlying cause</a> for bleeding (such as conditions predisposing to bleeding, including haemophilia or leukaemia), or if there is a comorbid condition (such as coronary artery disease or severe hypertension).</li></ul></li><li><strong>If bleeding does not stop after 10–15 minutes of nasal pressure and the appropriate expertise and facilities are available in primary care, </strong><strong>consider:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/acute-epistaxis/#nasal-cautery\">Nasal cautery</a><strong> </strong>— if the bleeding point can be seen and the procedure can be tolerated (for example in adults and older children, but not younger children).</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/acute-epistaxis/#nasal-packing\">Nasal packing</a> — if nasal cautery is ineffective or the bleeding point cannot be seen. Admit the person to hospital if a nasal pack has been inserted in primary care.</li></ul></li><li><strong>If bleeding does not stop after 10–15 minutes of nasal pressure and the appropriate expertise and facilities for cautery or packing are <em>not </em>available in primary care, </strong>transfer the person to Accident and Emergency immediately.</li><li><strong>If first aid measures or nasal cautery employed in primary care have resulted in cessation of bleeding, offer self-care advice.</strong> Recommend that for 24 hours, where practical, the person should avoid activities which may increase the risk of re-bleeding. These include:<ul><li>Blowing or picking the nose.</li><li>Heavy lifting.</li><li>Strenuous exercise.</li><li>Lying flat.</li><li>Drinking alcohol or hot drinks.</li></ul></li><li><strong>Advise the person that if bleeding restarts and does not respond to first aid measures (as above) they should seek urgent medical advice.</strong></li><li><strong>If there is a history of recurrent epistaxis, consider whether referral is necessary. </strong>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/recurrent-epistaxis/#management-of-recurrent-epistaxis\">Management of recurrent epistaxis</a> for more information.</li></ul><!-- end field 88b5dffb-725a-40b8-908f-025a9c8ba427 --><!-- end item 159eb36c-7ca8-454b-a5b3-b716663a3fee -->","subChapters":[{"id":"e62f953b-0f4f-5cd9-bea6-149db5d6dcef","slug":"nasal-cautery","fullItemName":"Nasal cautery","depth":4,"htmlHeader":"<!-- begin field 6f3f8fb5-2e97-4af8-872e-28d30d4d4062 --><h4>Nasal cautery</h4><!-- end field 6f3f8fb5-2e97-4af8-872e-28d30d4d4062 -->","summary":null,"htmlStringContent":"<!-- begin item 0b2326f9-c62d-4043-8721-3fa1aaff06e7 --><!-- begin field a0d2370f-5518-4d12-8a37-ff114fbebafd --><ul><li><strong>Consider nasal cautery in primary care if:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/acute-epistaxis/#management-of-acute-epistaxis\">First aid measures</a> have not worked, <em>and</em></li><li>The appropriate expertise and facilities (good lighting, topical anaesthetic spray, and nasal speculum) are available, <em>and</em></li><li>It can be tolerated (for example in adults and older children, but not younger children).</li></ul></li><li><strong>Prior to cautery</strong><strong>:</strong><ul><li>Ask the person to blow their nose to clear any clots and allow local anaesthetic to be applied. This may restart the bleeding.</li><li>Use a topical local anaesthetic spray, preferably with a vasoconstrictor (such as lidocaine with phenylephrine [Co-phenylcaine<sup>®</sup>]), prior to cauterizing the area. Wait 3–4 minutes for the full effect. The vasoconstrictor may stop the bleeding, but once the effects have worn off, the bleeding may start again.</li></ul></li><li><strong>To cauterize</strong><strong>:</strong><ul><li>Identify the bleeding point — it will look like a small red dot (less than 1 mm) and may not be actively bleeding.</li><li>Lightly apply the silver nitrate stick to the bleeding point for 3–10 seconds until a grey-white colour develops.<ul><li>Only cauterize one side of the septum to avoid nasal septal perforation.</li><li>Avoid touching areas which do not need treatment (for example facial skin).</li></ul></li></ul></li><li><strong>After cautery</strong><strong>:</strong><ul><li>Dab the cauterized area with a clean cotton bud to remove excess chemical or blood.</li><li>Apply a topical antiseptic preparation to the area:<ul><li>Prescribe Naseptin<sup>® </sup>(chlorhexidine and neomycin) cream first line, to be applied to the nostrils four times daily for 10 days.</li><li>If the person is allergic to neomycin, peanut, or soya, do not prescribe Naseptin<sup>®</sup>. Consider prescribing mupirocin nasal ointment to be applied to the nostrils two to three times a day for 5–7 days.</li></ul></li><li>Do not routinely pack the affected side.</li><li>Advise<strong> </strong>the person to avoid blowing their nose for a few hours to prevent straining of the nostril.</li></ul></li></ul><!-- end field a0d2370f-5518-4d12-8a37-ff114fbebafd --><!-- end item 0b2326f9-c62d-4043-8721-3fa1aaff06e7 -->","subChapters":[]},{"id":"9c42a979-c6a4-547c-92f3-119eae21be5f","slug":"nasal-packing","fullItemName":"Nasal packing","depth":4,"htmlHeader":"<!-- begin field c00b8927-8b4d-4e7a-98c4-a94c1cc65f82 --><h4>Nasal packing</h4><!-- end field c00b8927-8b4d-4e7a-98c4-a94c1cc65f82 -->","summary":null,"htmlStringContent":"<!-- begin item bc05e371-1bb3-4434-b0a9-15f7d11ad824 --><!-- begin field f133a818-94dc-4fe2-bd96-ec9fadda0794 --><ul><li><strong>Consider nasal packing in primary care if:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/management/acute-epistaxis/#nasal-cautery\">Nasal cautery</a> has been ineffective <em>or </em>the bleeding point cannot be seen, <em>and</em></li><li>The appropriate expertise and facilities (good lighting, topical anaesthetic spray, and nasal speculum) are available.</li></ul></li><li><strong>Prior to packing:</strong><ul><li>Anaesthetize the nasal cavity with topical local anaesthetic spray, preferably one with a vasoconstrictor (for example lidocaine with phenylephrine [Co-phenylcaine<sup>®</sup>]), if this has not already been done. Wait 3–4 minutes for the full effect.</li></ul></li><li><strong>Nasal packing products</strong><ul><li>The decision on which nasal packing product to use is based on availability, cost, and preference. The available products include:<ul><li>Nasal tampons (for example Merocel<sup>®</sup>) — effective and easy to use.</li><li>Inflatable packs (for example Rapid-Rhino<sup>®</sup>) — effective and may be easier and more comfortable to insert and remove than nasal tampons.</li><li>Ribbon gauze impregnated with Vaseline<sup>® </sup>or bismuth-iodoform paraffin paste — packing with ribbon gauze is not recommended in primary care without specific training.</li></ul></li></ul></li><li><strong>Insert the packing according to the manufacturers' instructions.</strong><ul><li>Pack the person's nostril whilst they are sitting with their head tilted forward. Ensure that the person is holding a receptacle to spit blood out in, and is breathing through the mouth.</li><li>Secure the pack (for example Merocel<sup>® </sup>packs have a string attached which can be taped to the cheek), and ensure there is no pressure on the cartilage around the nostril as this can cause a cosmetic defect.</li><li>Check the oropharynx for signs of bleeding from the back of the nose. If bleeding is seen, consider packing the other nostril to increase pressure on the bleeding vessel.</li></ul></li><li><strong>Admit the person to hospital for observation, preferably to an ear, nose, and throat department.</strong></li></ul><!-- end field f133a818-94dc-4fe2-bd96-ec9fadda0794 --><!-- end item bc05e371-1bb3-4434-b0a9-15f7d11ad824 -->","subChapters":[]},{"id":"4a3e56d5-320a-556f-94c0-917d7ad2203a","slug":"secondary-care-treatments","fullItemName":"Secondary care treatments","depth":4,"htmlHeader":"<!-- begin field f71b672f-e59f-4aef-adba-4e8d9d877aaf --><h4>Secondary care treatments</h4><!-- end field f71b672f-e59f-4aef-adba-4e8d9d877aaf -->","summary":null,"htmlStringContent":"<!-- begin item 44beaa62-7284-4cee-9a71-1ffc52720664 --><!-- begin field 3c6abbba-7694-4d62-93ec-798da8dfe381 --><ul><li><strong>Secondary care treatments for acute epistaxis include:</strong><ul><li>Resuscitation — this may include transfusion to replace blood volume and provide coagulation factors.</li><li>Formal packing (may be under general anaesthetic).</li><li>Endoscopic assessment and electrocautery.</li><li>Examination under anaesthesia, and surgical intervention (such as diathermy, septal surgery, arterial ligation, and laser treatment).</li><li>Radiological arterial embolization.</li><li>Intravenous or oral tranexamic acid.</li></ul></li></ul><!-- end field 3c6abbba-7694-4d62-93ec-798da8dfe381 --><!-- end item 44beaa62-7284-4cee-9a71-1ffc52720664 -->","subChapters":[]},{"id":"61dcd9ba-3ae2-5433-a337-0c01f3e9b596","slug":"basis-for-recommendation-bb7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7a340405-b8d7-4245-b7ba-1b6dc7356cab --><h4>Basis for recommendation</h4><!-- end field 7a340405-b8d7-4245-b7ba-1b6dc7356cab -->","summary":null,"htmlStringContent":"<!-- begin item bb793f36-8aaf-4b2b-9ca0-b3991b004dee --><!-- begin field 408893f9-e63d-48c3-81c0-5aedb286408b --><p>The recommendations on management of a person with acute epistaxis are based on expert opinion within an American guideline <em>Epistaxis: an overview</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kasperek and Pollock, 2013</a>], the BMJ Best Practice Guideline <em>Epistaxis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">BMJ Best Practice, 2018</a>], and a number of narrative review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Makura et al, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Pashen and Stevens, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Wormald, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Crown and Criner, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Aneeshkumar et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kucik and Clenney, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Leong et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Pope and Hobbs, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Daudia et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Schlosser, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Mulla et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Patel and Fowell, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Jayakody, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Womack et al, 2018</a>].</p><h5>Referral to secondary care</h5><ul><li>For people with a suspected posterior nosebleed, referral to secondary care is recommended because complications, such as bradycardia, hypotension, hypoventilation, or aspiration from dislodgement or malpositioning, are more likely to occur [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kasperek and Pollock, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Patel and Fowell, 2013</a>].</li><li>For children younger than 2 years of age, consideration of referral to secondary care is recommended because epistaxis in this age group is rare and is often associated with injury or serious illness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">McIntosh et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Patel et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Siddiq and Grainger, 2015</a>].</li><li>For people with an underlying cause for bleeding, consideration of referral is recommended so that they can be managed appropriately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Pashen and Stevens, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Wormald, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Crown and Criner, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kucik and Clenney, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Leong et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Daudia et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Schlosser, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Patel and Fowell, 2013</a>].</li><li>For people with a comorbid condition, admission to hospital is recommended because although mortality from epistaxis is rare, it most commonly occurs in people with comorbidities such as coronary artery disease, severe hypertension, a clotting disorder, or significant anaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kucik and Clenney, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Schlosser, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">McGarry, 2013</a>].</li></ul><h5>Topical antiseptic treatments</h5><ul><li>The recommendation to prescribe a topical antiseptic preparation is based on the opinion of a previous expert reviewer of this CKS topic, who suggested that as well as their antimicrobial action, topical treatments can act as a barrier to further trauma and preserve the humidity of the lining of the nose.</li><li>The suggested four times a day dosing regimen for Naseptin<sup>® </sup>(chlorhexidine and neomycin) cream derives from the manufacturer's Summary of Product Characteristic (SPC) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">ABPI, 2017a</a>], but it was the opinion of  previous CKS expert reviewers of this topic that a twice-daily regimen for up to 2 weeks is acceptable if compliance is an issue.</li><li>The manufacturer of Naseptin<sup>® </sup>cream advises that it should be avoided in people with a peanut allergy as it contains arachis oil (peanut oil). As there is a possible relationship between allergy to peanut and allergy to soya, people with soya allergy should also avoid Naseptin<sup>® </sup>cream [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">ABPI, 2017a</a>].</li><li>The suggested dosing regimen for mupirocin nasal ointment is taken from the manufacturer's SPC [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">ABPI, 2017b</a>].</li></ul><!-- end field 408893f9-e63d-48c3-81c0-5aedb286408b --><!-- end item bb793f36-8aaf-4b2b-9ca0-b3991b004dee -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}